Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Titel:
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
Auteur:
Hortobagyi, G.N. Stemmer, S.M. Burris, H.A. Yap, Y.S. Sonke, G.S. Paluch-Shimon, S. Campone, M. Petrakova, K. Blackwell, K.L. Winer, E.P. Janni, W. Verma, S. Conte, P. Arteaga, C.L. Cameron, D.A. Mondal, S. Su, F. Miller, M. Elmeliegy, M. Germa, C. O’Shaughnessy, J.